Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Interactions of commonly used dietary supplements with cardiovascular drugs: a systematic review.

Kanji S, Seely D, Yazdi F, Tetzlaff J, Singh K, Tsertsvadze A, Tricco AC, Sears ME, Ooi TC, Turek MA, Skidmore B, Ansari MT.

Syst Rev. 2012 May 31;1:26. doi: 10.1186/2046-4053-1-26. Review.

2.

Dietary Supplements in Adults Taking Cardiovascular Drugs [Internet].

Seely D, Kanji S, Yazdi F, Tetzlaff J, Singh K, Tsertsvadze A, Sears ME, Tricco A, Ooi TC, Turek M, Tsouros S, Skidmore B, Daniel R, Ansari MT.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Apr.

3.

The efficacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: a systematic review for a National Institutes of Health state-of-the-science conference.

Huang HY, Caballero B, Chang S, Alberg AJ, Semba RD, Schneyer CR, Wilson RF, Cheng TY, Vassy J, Prokopowicz G, Barnes GJ 2nd, Bass EB.

Ann Intern Med. 2006 Sep 5;145(5):372-85. Epub 2006 Jul 31. Review.

PMID:
16880453
4.

Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review.

Marik PE, Varon J.

Clin Cardiol. 2009 Jul;32(7):365-72. doi: 10.1002/clc.20604. Review.

5.

Chemoprevention of colorectal cancer: systematic review and economic evaluation.

Cooper K, Squires H, Carroll C, Papaioannou D, Booth A, Logan RF, Maguire C, Hind D, Tappenden P.

Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320. Review.

6.

Omega 3 Fatty acids and cardiovascular outcomes: systematic review and meta-analysis.

Kotwal S, Jun M, Sullivan D, Perkovic V, Neal B.

Circ Cardiovasc Qual Outcomes. 2012 Nov;5(6):808-18. doi: 10.1161/CIRCOUTCOMES.112.966168. Epub 2012 Oct 30. Review.

7.
8.

Nutrition and dietary supplements.

Fillmore CM, Bartoli L, Bach R, Park Y.

Phys Med Rehabil Clin N Am. 1999 Aug;10(3):673-703. Review.

PMID:
10516985
9.

Do dietary supplements have beneficial health effects in industrialized nations: what is the evidence?

Marik PE, Flemmer M.

JPEN J Parenter Enteral Nutr. 2012 Mar;36(2):159-68. doi: 10.1177/0148607111416485. Epub 2012 Jan 24. Review.

PMID:
22275325
10.

Systematic review of herbs and dietary supplements for glycemic control in diabetes.

Yeh GY, Eisenberg DM, Kaptchuk TJ, Phillips RS.

Diabetes Care. 2003 Apr;26(4):1277-94. Review.

PMID:
12663610
11.

Evaluation of the antihyperlipidemic properties of dietary supplements.

Caron MF, White CM.

Pharmacotherapy. 2001 Apr;21(4):481-7. Review.

PMID:
11310521
12.

Garlic supplementation and serum cholesterol: a meta-analysis.

Khoo YS, Aziz Z.

J Clin Pharm Ther. 2009 Apr;34(2):133-45. doi: 10.1111/j.1365-2710.2008.00998.x. Review.

PMID:
19250134
13.

Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force.

Wolff T, Witkop CT, Miller T, Syed SB; U.S. Preventive Services Task Force.

Ann Intern Med. 2009 May 5;150(9):632-9. Review.

PMID:
19414843
14.

Patient use of dietary supplements: a clinician's perspective.

Sadovsky R, Collins N, Tighe AP, Brunton SA, Safeer R.

Curr Med Res Opin. 2008 Apr;24(4):1209-16. doi: 10.1185/030079908X280743 . Epub 2008 Mar 17. Review.

PMID:
18348745
15.

Dietary supplements for body-weight reduction: a systematic review.

Pittler MH, Ernst E.

Am J Clin Nutr. 2004 Apr;79(4):529-36. Review.

16.
17.

Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.

Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC, Smith WC, Jung RT, Campbell MK, Grant AM.

Health Technol Assess. 2004 May;8(21):iii-iv, 1-182. Review.

18.

Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.

Wilby J, Kainth A, Hawkins N, Epstein D, McIntosh H, McDaid C, Mason A, Golder S, O'Meara S, Sculpher M, Drummond M, Forbes C.

Health Technol Assess. 2005 Apr;9(15):1-157, iii-iv. Review.

19.

Efficacy and safety of innovator versus generic drugs in patients with epilepsy: a systematic review.

Talati R, Scholle JM, Phung OP, Baker EL, Baker WL, Ashaye A, Kluger J, Coleman CI, White CM.

Pharmacotherapy. 2012 Apr;32(4):314-22. doi: 10.1002/j.1875-9114.2012.01099.x. Review.

PMID:
22461121
20.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
Items per page

Supplemental Content

Write to the Help Desk